ARIDIS PHARMACEUTICALS INC (ARDS)

US0403341045 - Common Stock

0.3101  +0.05 (+17.91%)

After market: 0.2619 -0.05 (-15.54%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.99M3.09M1.54M1.00M1.02M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
31.82M33.08M44.24M23.40M30.11M
Research and Development
25.00M25.92M36.94M16.96M24.08M
Selling, General, and Administrative Expenses
6.81M7.16M7.31M6.45M6.03M
Operating Income
-28.83M-29.99M-42.71M-22.40M-29.09M
Interest Income/Expense
154.00K-121.00K-250.00K70.00K-590.00K
Other Income/Expense
-743.00K-257.00K40.00KN/AN/A
Non Recurring Items
N/A0.00720.00KN/AN/A
Income Before Taxes
-29.42M-30.37M-42.19M-22.33M-29.68M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-29.42M-30.37M-46.32M-22.33M-29.68M
EBITDA
-28.39M-29.51M-42.27M-22.06M-28.75M
 
Per Share Data
EPS Diluted Total Ops
-1.43-1.62-3.77-2.44-3.51
Non GAAP EPS
N/A-1.96-4.18-2.44-3.52
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-985.30%-982.56%-3007.79%-2233.00%-2909.80%
Operating Profit Margin
-965.57%-970.33%-2773.38%-2240.00%-2851.96%

All data in USD

Charts